Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.

Zhang Q,Bastard P,Liu Z,Le Pen J,Moncada-Velez M,Chen J,Ogishi M,Sabli I,Hodeib S,Korol C,Rosain J,Bilguvar K,Ye J,Bolze A,Bigio B,Yang R,Arias A,Zhou Q,Zhang Y,Onodi F,Korniotis S,Karpf L,Philippot Q,Chbihi M,Bonnet-Madin L,Dorgham K,Smith N,Schneider W,Razooky B,Hoffmann H,Michailidis E,Moens L,Han J,Lorenzo L,Bizien L,Meade P,Neehus A,Ugurbil A,Corneau A,Kerner G,Zhang P,Rapaport F,Seeleuthner Y,Manry J,Masson C,Schmitt Y,Schlüter A,Le Voyer T,Khan T,Li J,Fellay J,Roussel L,Shahrooei M,Alosaimi M,Mansouri D,Al-Saud H,Al-Mulla F,Almourfi F,Al-Muhsen S,Alsohime F,Al Turki S,Hasanato R,van de Beek D,Biondi A,Bettini L,D'Angio' M,Bonfanti P,Imberti L,Sottini A,Paghera S,Quiros-Roldan E,Rossi C,Oler A,Tompkins M,Alba C,Vandernoot I,Goffard J,Smits G,Migeotte I,Haerynck F,Soler-Palacin P,Martin-Nalda A,Colobran R,Morange P,Keles S,Çölkesen F,Ozcelik T,Yasar K,Senoglu S,Karabela Ş,Rodríguez-Gallego C,Novelli G,Hraiech S,Tandjaoui-Lambiotte Y,Duval X,Laouénan C,Snow A,Dalgard C,Milner J,Vinh D,Mogensen T,Marr N,Spaan A,Boisson B,Boisson-Dupuis S,Bustamante J,Puel A,Ciancanelli M,Meyts I,Maniatis T,Soumelis V,Amara A,Nussenzweig M,García-Sastre A,Krammer F,Pujol A,Duffy D,Lifton R,Zhang S,Gorochov G,Béziat V,Jouanguy E,Sancho-Shimizu V,Rice C,Abel L,Notarangelo L,Cobat A,Su H,Casanova J

Source :

Science

2020 Sep 24

Pmid / DOI:

32972995

Abstract

Clinical outcome upon infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ranges from silent infection to lethal coronavirus disease 2019 (COVID-19). We have found an enrichment in rare variants predicted to be loss-of-function (LOF) at the 13 human loci known to govern Toll-like receptor 3 (TLR3)- and interferon regulatory factor 7 (IRF7)-dependent type I interferon (IFN) immunity to influenza virus in 659 patients with life-threatening COVID-19 pneumonia relative to 534 subjects with asymptomatic or benign infection. By testing these and other rare variants at these 13 loci, we experimentally defined LOF variants underlying autosomal-recessive or autosomal-dominant deficiencies in 23 patients (3.5%) 17 to 77 years of age. We show that human fibroblasts with mutations affecting this circuit are vulnerable to SARS-CoV-2. Inborn errors of TLR3- and IRF7-dependent type I IFN immunity can underlie life-threatening COVID-19 pneumonia in patients with no prior severe infection.Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Voir la publication

Toutes les publications